Hansoh Pharmac Hd 00001 Stock Profit Margin
| 3KY Stock | EUR 2.16 0.06 2.70% |
HANSOH PHARMAC HD 00001 fundamentals help investors to digest information that contributes to HANSOH PHARMAC's financial success or failures. It also enables traders to predict the movement of HANSOH Stock. The fundamental analysis module provides a way to measure HANSOH PHARMAC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HANSOH PHARMAC stock.
HANSOH |
HANSOH PHARMAC HD 00001 Company Profit Margin Analysis
HANSOH PHARMAC's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current HANSOH PHARMAC Profit Margin | 0.27 % |
Most of HANSOH PHARMAC's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HANSOH PHARMAC HD 00001 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, HANSOH PHARMAC HD 00001 has a Profit Margin of 0.2729%. This is 102.43% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all Germany stocks is 121.49% lower than that of the firm.
HANSOH Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HANSOH PHARMAC's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HANSOH PHARMAC could also be used in its relative valuation, which is a method of valuing HANSOH PHARMAC by comparing valuation metrics of similar companies.HANSOH PHARMAC is number one stock in profit margin category among its peers.
HANSOH Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.063 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.28 % | |||
| Shares Outstanding | 5.92 B | |||
| Shares Owned By Insiders | 81.92 % | |||
| Shares Owned By Institutions | 7.99 % | |||
| Price To Earning | 38.60 X | |||
| Revenue | 9.97 B | |||
| Gross Profit | 9.06 B | |||
| EBITDA | 3.02 B | |||
| Net Income | 2.57 B | |||
| Cash And Equivalents | 13.73 B | |||
| Cash Per Share | 2.32 X | |||
| Total Debt | 92.75 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.43 X | |||
| Book Value Per Share | 3.57 X | |||
| Cash Flow From Operations | 2.39 B | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 10.78 K | |||
| Beta | 0.57 | |||
| Market Capitalization | 11.47 B | |||
| Z Score | 73.8 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.12 |
About HANSOH PHARMAC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HANSOH PHARMAC HD 00001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HANSOH PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HANSOH PHARMAC HD 00001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HANSOH Stock
HANSOH PHARMAC financial ratios help investors to determine whether HANSOH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HANSOH with respect to the benefits of owning HANSOH PHARMAC security.